A flurry of announcements relating to COVID vaccines dominated headlines on the pandemic on Monday, with Moderna telling investors it expects to generate some $5 billion in sales in 2023. Read more
Tag: Biopharmaceuticals
Pfizer and BioNTech updated booster shows strong results against new omicron sublineages in fresh analysis of data
A fresh analysis of data on the immune response generated by the bivalent COVID-19 booster showed strong results against the newer omicron sublineages, Pfizer and German partner BioNTech said Friday. Read more
AstraZeneca lifts guidance after forecast-beating profit and sales
AstraZeneca PLC on Thursday lifted its guidance for the full year after reporting a swing to net profit and higher sales for the third quarter of the year, which both Read more
Pfizer-BioNTech bivalent booster shows higher immune response, but new COVID cases climb back above 40,000 a day
First the good news: Pfizer Inc. and Germany-based partner BioNTech SE said updated trial data for their omicron BA.4/BA.5-adapted bivalent booster showed a “substantially higher” immune response in adults than Read more
Short sellers hit back at Cassava lawsuit against them: ‘We stand behind everything we wrote’
The defendants in a defamation lawsuit brought by Cassava Sciences have hit back at the plaintiff, saying it’s one of the most “frivolous” lawsuits they’ve seen. Biotech company Cassava Sciences Read more
AstraZeneca says advanced trial of breast-cancer drug Capivasertib meets primary endpoints
AstraZeneca PLC said Wednesday that Capivasertib plus Faslodex significantly improved progression-free survival when compared with Faslodex combined with a placebo in a Phase 3 trial in advanced hormone receptor-positive breast Read more
Pfizer sets new prices for its COVID-19 vaccines. The cost? $110 to $130 per dose
Pfizer Inc. PFE, +3.06% said Thursday that it plans to sell the COVID-19 shot it developed with BioNTech SE BNTX, +4.59% for $110 to $130 per dose once the U.S. Read more
Pfizer sets new prices for its COVID-19 vaccines. The cost? $110 to $130 per dose
Pfizer Inc. PFE, +4.67% said Thursday that it plans to sell the COVID-19 shot it developed with BioNTech SE BNTX, +7.02% for $110 to $130 per dose once the U.S. Read more
Fresh data supports updated boosters targeting omicron subvariants, raising hopes more Americans will get the shot
A flurry of announcements Thursday on COVID vaccines and boosters offered further evidence and support for the new bivalent boosters that target the most dominant virus strains and experts are Read more
Fresh data supports updated boosters targeting omicron subvariants, raising hopes more Americans will get the shot
A flurry of announcements Thursday on COVID vaccines and boosters offered further evidence and support for the new bivalent boosters that target the most dominant virus strains and experts are Read more